ID   LEF1_RAT                Reviewed;         397 AA.
AC   Q9QXN1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=Lymphoid enhancer-binding factor 1 {ECO:0000312|RGD:620241};
DE            Short=LEF-1 {ECO:0000303|PubMed:10824856};
GN   Name=Lef1 {ECO:0000312|RGD:620241};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=10824856;
RA   Kobielak K., Kobielak A., Trzeciak W.H.;
RT   "Cloning of the lymphoid enhancer binding factor-1 (Lef-1) cDNA from rat
RT   kidney: homology to the mouse sequence.";
RL   Acta Biochim. Pol. 46:885-888(1999).
CC   -!- FUNCTION: Transcription factor that binds DNA in a sequence-specific
CC       manner (By similarity). Participates in the Wnt signaling pathway (By
CC       similarity). Activates transcription of target genes in the presence of
CC       CTNNB1 and EP300 (By similarity). PIASG antagonizes both Wnt-dependent
CC       and Wnt-independent activation by LEF1 (By similarity). TLE1, TLE2,
CC       TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1 (By
CC       similarity). Regulates T-cell receptor alpha enhancer function (By
CC       similarity). Required for IL17A expressing gamma-delta T-cell
CC       maturation and development, via binding to regulator loci of BLK to
CC       modulate expression (By similarity). Acts as a positive regulator of
CC       odontoblast differentiation during mesenchymal tooth germ formation,
CC       expression is repressed during the bell stage by MSX1-mediated
CC       inhibition of CTNNB1 signaling (By similarity). May play a role in hair
CC       cell differentiation and follicle morphogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:P27782, ECO:0000250|UniProtKB:Q9UJU2}.
CC   -!- SUBUNIT: Binds the armadillo repeat of CTNNB1 and forms a stable
CC       complex. Interacts with TLE1, PIASG, ALYREF/THOC4, EP300, MDFI and
CC       MDFIC (By similarity). Interacts with DAZAP2 (By similarity).
CC       {ECO:0000250|UniProtKB:P27782, ECO:0000250|UniProtKB:Q9UJU2}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.
CC       Note=Found in nuclear bodies upon PIASG binding. {ECO:0000250}.
CC   -!- DOMAIN: Proline-rich and acidic regions are implicated in the
CC       activation functions of RNA polymerase II transcription factors.
CC   -!- PTM: Phosphorylated at Thr-153 and/or Ser-164 by NLK (By similarity).
CC       Phosphorylation by NLK at these sites represses LEF1-mediated
CC       transcriptional activation of target genes of the canonical Wnt
CC       signaling pathway (By similarity). {ECO:0000250|UniProtKB:Q9UJU2}.
CC   -!- SIMILARITY: Belongs to the TCF/LEF family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF198533; AAF15601.1; -; mRNA.
DR   RefSeq; NP_569113.1; NM_130429.1.
DR   AlphaFoldDB; Q9QXN1; -.
DR   BMRB; Q9QXN1; -.
DR   SMR; Q9QXN1; -.
DR   BioGRID; 250906; 1.
DR   IntAct; Q9QXN1; 1.
DR   MINT; Q9QXN1; -.
DR   STRING; 10116.ENSRNOP00000013694; -.
DR   iPTMnet; Q9QXN1; -.
DR   PhosphoSitePlus; Q9QXN1; -.
DR   PaxDb; 10116-ENSRNOP00000013694; -.
DR   GeneID; 161452; -.
DR   KEGG; rno:161452; -.
DR   AGR; RGD:620241; -.
DR   CTD; 51176; -.
DR   RGD; 620241; Lef1.
DR   eggNOG; KOG3248; Eukaryota.
DR   InParanoid; Q9QXN1; -.
DR   OrthoDB; 5351131at2759; -.
DR   PhylomeDB; Q9QXN1; -.
DR   Reactome; R-RNO-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-RNO-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-4641265; Repression of WNT target genes.
DR   Reactome; R-RNO-8951430; RUNX3 regulates WNT signaling.
DR   Reactome; R-RNO-9825892; Regulation of MITF-M-dependent genes involved in cell cycle and proliferation.
DR   PRO; PR:Q9QXN1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:1990907; C:beta-catenin-TCF complex; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032993; C:protein-DNA complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0070016; F:armadillo repeat domain binding; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; ISO:RGD.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0008301; F:DNA binding, bending; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0045295; F:gamma-catenin binding; ISO:RGD.
DR   GO; GO:0042393; F:histone binding; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; ISO:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISO:RGD.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; ISO:RGD.
DR   GO; GO:0046632; P:alpha-beta T cell differentiation; ISO:RGD.
DR   GO; GO:0060033; P:anatomical structure regression; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:1902262; P:apoptotic process involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0060561; P:apoptotic process involved in morphogenesis; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IEP:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:RGD.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISO:RGD.
DR   GO; GO:0071353; P:cellular response to interleukin-4; ISO:RGD.
DR   GO; GO:0060710; P:chorio-allantoic fusion; ISO:RGD.
DR   GO; GO:0021542; P:dentate gyrus development; ISO:RGD.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISO:RGD.
DR   GO; GO:1904019; P:epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0021873; P:forebrain neuroblast division; ISO:RGD.
DR   GO; GO:0021861; P:forebrain radial glial cell differentiation; ISO:RGD.
DR   GO; GO:0021943; P:formation of radial glial scaffolds; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0071866; P:negative regulation of apoptotic process in bone marrow cell; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0032696; P:negative regulation of interleukin-13 production; ISO:RGD.
DR   GO; GO:0032713; P:negative regulation of interleukin-4 production; ISO:RGD.
DR   GO; GO:0032714; P:negative regulation of interleukin-5 production; ISO:RGD.
DR   GO; GO:0045843; P:negative regulation of striated muscle tissue development; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030223; P:neutrophil differentiation; ISO:RGD.
DR   GO; GO:0071895; P:odontoblast differentiation; IMP:RGD.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0048341; P:paraxial mesoderm formation; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0071864; P:positive regulation of cell proliferation in bone marrow; ISO:RGD.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0030854; P:positive regulation of granulocyte differentiation; ISO:RGD.
DR   GO; GO:1901331; P:positive regulation of odontoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0071168; P:protein localization to chromatin; ISO:RGD.
DR   GO; GO:0022407; P:regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0062009; P:secondary palate development; ISO:RGD.
DR   GO; GO:0050909; P:sensory perception of taste; ISO:RGD.
DR   GO; GO:0043588; P:skin development; IEP:RGD.
DR   GO; GO:0001756; P:somitogenesis; ISO:RGD.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0033153; P:T cell receptor V(D)J recombination; ISO:RGD.
DR   GO; GO:0045063; P:T-helper 1 cell differentiation; ISO:RGD.
DR   GO; GO:0043586; P:tongue development; ISO:RGD.
DR   GO; GO:0061153; P:trachea gland development; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001944; P:vasculature development; ISO:RGD.
DR   CDD; cd21996; HMG-box_TCF7-like; 1.
DR   Gene3D; 1.10.30.10; High mobility group box domain; 1.
DR   Gene3D; 4.10.900.10; TCF3-CBD (Catenin binding domain); 1.
DR   InterPro; IPR027397; Catenin-bd_sf.
DR   InterPro; IPR013558; CTNNB1-bd_N.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR024940; TCF/LEF.
DR   PANTHER; PTHR10373:SF11; LYMPHOID ENHANCER-BINDING FACTOR 1; 1.
DR   PANTHER; PTHR10373; TRANSCRIPTION FACTOR 7 FAMILY MEMBER; 1.
DR   Pfam; PF08347; CTNNB1_binding; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; HMG-box; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Wnt signaling pathway.
FT   CHAIN           1..397
FT                   /note="Lymphoid enhancer-binding factor 1"
FT                   /id="PRO_0000048597"
FT   DNA_BIND        297..365
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   REGION          1..60
FT                   /note="CTNNB1-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          38..102
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          164..190
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          367..397
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        80..97
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..296
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJU2"
FT   MOD_RES         153
FT                   /note="Phosphothreonine; by NLK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJU2"
FT   MOD_RES         164
FT                   /note="Phosphoserine; by NLK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJU2"
FT   CROSSLNK        25
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        267
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   397 AA;  44023 MW;  D6BEFF805CB526EA CRC64;
     MPQLSGGGGG GDPELCATDE MIPFKDEGDP QKEKIFAEIS HPEEEGDLAD IKSSLVNESE
     IIPASNGHEV VGQTQSSQEP YHDKAREHPD DGKHPDGGLY NKGPSYSSYS GYIMMPNMNS
     DPYMSNGSLS PPIPRTSNKV PVVQPSHAVH PLTPLITYSD EHFSPGSHPS HIPSEVNPKQ
     GMSRHPPAPE MPTFYPLSPG GVGQITPPLG WQGQPVYPIT GGFRQAYPSS LSGDTSMSRF
     SHHMIPGPPG PHTTGIPHPA IVTPQVKQEH PHTDSDLMHV KPEHEQRKEQ EPKRPHIKKP
     LNAFMLYMKE MRANVVAECT LKESAAINQI LGRRWHALSR EEQAKYYELA RKERQLHMQL
     YPGWSARDNY GKKKKRKREK LQESTSGTGP RMTAAYI
//
